MMP1 and metastatic malignant neoplasm in the lymph nodes: In the present study, we suggest that salivary MMP-1 is a good biomarker for (i) early-stage OSCC screening of high-risk populations; (ii) monitoring OSCC progression or disease recurrence; (iii) monitoring the status of neck lymph node metastasis in OSCC.